Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02108743
What this trial is testing

Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension.
American Medical Association Foundation
Not applicableStudy completedNCT04451850
What this trial is testing

HRV as a Marker of Treatment Response in PAH Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Cincinnati 24
Post-approval studies (Phase 4)Study completedNCT02891850
What this trial is testing

Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 225
Post-approval studies (Phase 4)Study completedNCT05439460
What this trial is testing

Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Stanford University 15
Not applicableStudy completedNCT05624242
What this trial is testing

Assessment of Right Ventricular Function by Cardiac MRI in Patients With Pulmonary Arterial Hypertension (IRMA)

Who this might be right for
Pulmonary Arterial Hypertension
Central Hospital, Nancy, France 112
Large-scale testing (Phase 3)Study completedNCT00578786
What this trial is testing

A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 383
Early research (Phase 1)Study completedNCT05567367
What this trial is testing

A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234

Who this might be right for
Healthy Volunteer
Respira Therapeutics, Inc. 31
Large-scale testing (Phase 3)Study completedNCT02558231
What this trial is testing

The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 247
Large-scale testing (Phase 3)Study completedNCT00454207
What this trial is testing

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 44
Large-scale testing (Phase 3)Ended earlyNCT00796666
What this trial is testing

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 131
Large-scale testing (Phase 3)Study completedNCT00644605
What this trial is testing

Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 275
Not applicableEnded earlyNCT00995566
What this trial is testing

A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer 54
Not applicableStudy completedNCT00377949
What this trial is testing

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients

Who this might be right for
Systemic SclerosisSclerodermaPulmonary Hypertension+1 more
Georgetown University 602
Early research (Phase 1)UnknownNCT02403908
What this trial is testing

Catheter Denervation of Pulmonary Arteries in Treatment of IPAH & SPAH

Who this might be right for
Hypertension, Pulmonary
Clinical Hospital Centre Zagreb 60
Large-scale testing (Phase 3)Study completedNCT03904693
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Actelion 187
Not applicableNot Yet RecruitingNCT07613216
What this trial is testing

A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Sarcoidosis LungPulmonary Hypertension+1 more
Cosmos Rx, Inc 100
Not applicableNo Longer AvailableNCT01897740
What this trial is testing

Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Not applicableLooking for participantsNCT07013149
What this trial is testing

The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
University of Sao Paulo General Hospital 183
Early research (Phase 1)Study completedNCT01798849
What this trial is testing

A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 25
Not applicableUnknownNCT04241497
What this trial is testing

Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism

Who this might be right for
Pulmonary Arterial HypertensionExercise TrainingHome-based Rehabilitation+5 more
Laval University 10
Next Page